Coexpression of ductular, hepatocytic, and HSC markers occurs in Hh-responsive multipotent liver progenitors that are undergoing epithelial-mesenchymal transitions.[9] Ninety-nine percent of 603B cells coexpress Krt7 (epithelial marker), vimentin (mesenchymal marker), and one or more Hh target genes (Patched [Ptc], glioblastoma [Gli]1, and Gli2), exhibiting the phenotype of multipotent liver progenitors that are in the midst of epithelial-mesenchymal transitions (Fig. 3A,B). qRT-PCR

analysis provided additional evidence that 603B cells are transitioning multipotent liver progenitors. Compared to freshly isolated primary hepatocytes from healthy adult mice, 603B cells express significantly Midostaurin mouse higher mRNA levels of Hh target genes (Ptc and Gli2), cholangiocyte-associated genes (e.g., Krt19 and HNF-6), and HSC-associated genes (e.g., Desmin and GFAP), but significantly lower mRNA levels of HNF-4α, a transcription factor that is strongly expressed by mature hepatocytes. As reported for transitional multipotent progenitors,[9] gene expression in 603B cells is more similar to HSCs than hepatocytes. For example, primary HSCs and 603B cells express comparable mRNA levels of Krt7, HNF-6, alpha-fetoprotein (AFP), Ptc, and Gli2. However,

mRNA levels of Desmin and GFAP are significantly lower in 603B cells than freshly isolated HSCs, and this discrepancy is magnified when HSCs undergo culture Tamoxifen research buy activation to become MFs (Fig. 3C). Nevertheless, the aggregate data demonstrate

genotypic and phenotypic similarities in Notch-responsive liver cells, and indicate that such cells are Hh responsive and inherently plastic (i.e., capable of undergoing epithelial-mesenchymal transitions). To investigate the functional significance of Notch signaling in HSCs, the Notch pathway was suppressed by treating cultured primary MFs/HSCs with a γ-secretase inhibitor (DAPT). Results in HSCs were compared to those in multipotent progenitor cells (603B), which served as a positive control for Notch signaling. As expected, studies in 603B cells showed that DAPT treatment significantly reduced expression of Jagged-1, Notch-2, and Notch target genes (Hes1, Hey1, and Hey2; Fig. 4). Inhibiting Notch signaling in 603B cells suppressed the expression of cholangiocyte-associated genes (Krt7, Krt19, HNF-1β, selleck and HNF-6) and permitted induction of hepatocyte lineage markers (AFP, HNF-1α, and HNF-4α), consistent with previous reports that activation of Notch signaling drives liver progenitors toward the biliary lineage, whereas its suppression promotes differentiation along the hepatocytic lineage.[2, 24, 25] Blocking Notch signaling in 603B enhanced expression of GFAP, a Q-HSC marker, but reduced α-SMA, an MF/HSC marker, and TGF-β, a profibrogenic cytokine that promotes ductular differentiation of liver progenitors in developing embryos.